Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma (JACCRO GY-01) - Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma (JACCRO GY-01)

Japanese Cancer Clinical Research Organization(JACCRO)0 sites70 target enrollmentDecember 24, 2009

Overview

No summary available.

Registry

who.int

Start Date

December 24, 2009

End Date

November 1, 2013

Last Updated

2 years ago

Study Type

Interventional

Sex

Female

Sponsor

Japanese Cancer Clinical Research Organization(JACCRO)

•1\) Patient with stump cancer 2\) Patient who has an active infection. 3\) Patient who has a hydronephrosis. 4\) Patient who has myocardial infarction, unstable angina and uncontrolled irregular heartbeat within six months before registration. 5\) Patient who has a serious complication. 6\) Patient who has a radiotherapy history in the pelvic region. 7\) Patient who has an active double cancer. However, cancers in situ that are considered as recovered by local treatment or legions equivalent to intramucosal cancer are not included in the active double cancers. 8\) Patient who underwent exploratory laparotomy for cervical cancer. 9\) Patient who is complicated by mental disease or psychological symptom and considered difficult to participate in the test. 10\) Patient who is pregnant or of child\-bearing potential or breast\-feeding. 11\) Patient who is diagnosed as a pyometra and there is no improvement in pyometra and infection despite the implementation of appropriate measures. 12\) Other cases where doctors in attendance consider patients inappropriate.